From the Desk of the CEO

On August 7, 2025, FDA issued a statement expressing concerns with the safety and effectiveness of unapproved, animal-derived thyroid medications.

Lauren Howell, PharmD

Hypertension is the most common and significant risk factor for diseases of the heart, kidneys, and brain, yet in the United States, it continues to be an uphill battle getting patients to goal.

Loren Bonner

The OTC regulatory classification presumes that users of OTC medications will read and heed the information in the product labeling. Medications that are capable of being labeled for safe and effective use without medical supervision are classified as “OTC” rather than as “Rx Only.”

David B. Brushwood, BSPharm, JD

With growing attention on mental health, researchers continue to explore how Mental Health First Aid training influences health care providers, in particular, pharmacists’ attitudes and competency to support individuals facing mental health challenges.

Loren Bonner

A new law in Hawai’i that recognizes pharmacists as providers—and enables reimbursement for their services—is being hailed as a major victory for patients and for the pharmacy profession in Hawai’i.

Loren Bonner